Amsterdam, Netherlands · Founded 2024 · Privately Held (backing)
Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. AviSia Therapeutics is based in Amsterdam, Netherlands and was founded in 2024. It has raised $410,000.
Last price · $/share
—
Implied valuation
—
Total raised
$410K
Last round
—
Team — not yet on record
No current team members for AviSia Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AviSia Therapeutics with a free account
·Watch AviSia Therapeutics: the Monday email on marks, rounds and moves
